Commentary: The Endocrine Society Clinical Practice Guideline and the North American Menopause Society position statement on androgen therapy in women: Another one of Yogi's forks

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4091-4093

  Braunstein, Glenn D ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE; TESTOSTERONE;

CLINICAL PRACTICE; DRUG SAFETY; ESTROGEN DEFICIENCY; EVIDENCE BASED PRACTICE; FEMALE; HORMONAL THERAPY; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; NOTE; OVARIECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEXUAL FUNCTION; UNITED STATES; WOMEN'S HEALTH; AGED; ARTICLE; BIOSYNTHESIS; MIDDLE AGED; PHYSIOLOGY; RISK ASSESSMENT; SEXUAL BEHAVIOR;

AGED; ANDROGENS; FEMALE; GUIDELINES AS TOPIC; HUMANS; MENOPAUSE; MIDDLE AGED; RISK ASSESSMENT; SEXUAL BEHAVIOR; TESTOSTERONE; WOMEN;

EID: 35948990817     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-1709     Document Type: Note

References (11)

1. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N 2006 Androgen therapy in women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:3697-3710
2. Shifren JL, Davis SR, Dennerstein L, Heiman JR, Lobo RA, Simon JA 2005 The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society. Menopause 12:497-511
3. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H 2007 Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92:405-413
4. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, Notelovitz M, Rosen R, Sarrel P, Sherwin B, Simon J, Simpson E, Shifren J, Spark R, Traish A 2002 Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril 77:60-665
5. Davis SR, Davison SL, Donath S, Bell RJ 2005 Circulating androgen levels and self-reported sexual function in women. JAMA 294:91-96
6. Braunstein GD 2007 Safety of testosterone treatment of postmenopausal women. Fertil Steril 88:1-17
7. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 91:1995-2010
8. Shames D, Gassman A, Handelsman H 2007 Commentary: guideline for male testosterone therapy: a regulatory perspective. J Clin Endocrinol Metab 92:414-415
9. Hofling M, Hirschberg AL, Skoog L, Tani E, Hagerstrom T, Von Shoultz B 2007 Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 14:183-190
10. Zang H, Sahlin L, Masironi B, Eriksson E, Hirschberg AL 2007 Effects of testosterone treatment on endometrial proliferation in postmenopausal women. J Clin Endocrinol Metab 92:2169-2175
11. Davis SR, Studd J, Bouchard C, Kroll R, Moufarage A, Von Schoulz B 2006 The effect of a testosterone transdermal system on hypoactive sexual desire disorder in postmenopausal women not receiving systemic estrogen therapy, the APHRODITE study. Program of the 88th Annual Meeting of The Endocrine Society, Boston, MA, June 24-27, 2006, p 43 (Abstract S38-1)